Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 20.80
+0.41 (2.01%)
Last updated: Jul 14, 2025
SHA:688163 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 46.57 | 44.29 | 38.77 | 64.2 | 76.48 | 63.17 | Upgrade |
Depreciation & Amortization | 19.97 | 19.97 | 17.16 | 14.9 | 15.04 | - | Upgrade |
Other Amortization | 0.37 | 0.37 | 0.24 | 0.24 | 0.24 | - | Upgrade |
Loss (Gain) From Sale of Assets | -1.44 | -1.44 | - | - | 0.25 | - | Upgrade |
Asset Writedown & Restructuring Costs | 1.03 | 1.03 | 0.02 | -0.95 | 1.02 | - | Upgrade |
Loss (Gain) From Sale of Investments | 1.01 | 1.01 | -10.33 | -16.04 | 0.79 | - | Upgrade |
Provision & Write-off of Bad Debts | 0.74 | 0.74 | 0.79 | -0.53 | 0.6 | - | Upgrade |
Other Operating Activities | 1.79 | 3.21 | 4.39 | 0.19 | 0.83 | 35.18 | Upgrade |
Change in Accounts Receivable | -10.42 | -10.42 | -22.99 | 3.2 | -4.48 | - | Upgrade |
Change in Inventory | -1.56 | -1.56 | 6.13 | -4.33 | -0.48 | - | Upgrade |
Change in Accounts Payable | -4.32 | -4.32 | -0.5 | 7.87 | 1 | - | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | 0.79 | - | Upgrade |
Operating Cash Flow | 51.12 | 50.25 | 32.82 | 67.91 | 92.29 | 98.35 | Upgrade |
Operating Cash Flow Growth | 72.45% | 53.12% | -51.67% | -26.41% | -6.17% | 20.16% | Upgrade |
Capital Expenditures | -55.82 | -59.37 | -28.67 | -26.46 | -27.61 | -17.92 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.02 | - | 0.33 | 0.01 | Upgrade |
Investment in Securities | 262.83 | 70.83 | -305 | -349.85 | -65 | 15 | Upgrade |
Other Investing Activities | 4.52 | 5.27 | 17.71 | 15.89 | 1.76 | 0.82 | Upgrade |
Investing Cash Flow | 211.53 | 16.73 | -315.94 | -360.42 | -90.52 | -2.1 | Upgrade |
Long-Term Debt Repaid | - | -1.15 | -0.69 | -1.34 | -1.31 | - | Upgrade |
Net Debt Issued (Repaid) | -1.15 | -1.15 | -0.69 | -1.34 | -1.31 | - | Upgrade |
Issuance of Common Stock | - | - | - | 790.61 | - | - | Upgrade |
Common Dividends Paid | -34.63 | -34.63 | -81.16 | -97.39 | - | -105.51 | Upgrade |
Dividends Paid | -34.63 | -34.63 | -81.16 | -97.39 | - | -105.51 | Upgrade |
Other Financing Activities | - | - | - | - | -2.7 | -3.85 | Upgrade |
Financing Cash Flow | -35.77 | -35.77 | -81.84 | 691.87 | -4.01 | -109.35 | Upgrade |
Foreign Exchange Rate Adjustments | -0.05 | -0.03 | 0.16 | 0.49 | -0.12 | -0.38 | Upgrade |
Net Cash Flow | 226.83 | 31.19 | -364.81 | 399.85 | -2.36 | -13.48 | Upgrade |
Free Cash Flow | -4.7 | -9.12 | 4.15 | 41.46 | 64.68 | 80.43 | Upgrade |
Free Cash Flow Growth | - | - | -90.00% | -35.91% | -19.58% | 41.77% | Upgrade |
Free Cash Flow Margin | -2.42% | -4.68% | 2.18% | 23.79% | 30.99% | 43.34% | Upgrade |
Free Cash Flow Per Share | -0.05 | -0.08 | 0.04 | 0.41 | 0.80 | 0.99 | Upgrade |
Cash Income Tax Paid | 13.78 | 13.33 | 25.02 | 12.86 | 16.85 | 18.29 | Upgrade |
Levered Free Cash Flow | -29.1 | -23.72 | -3.9 | 32.16 | 34.48 | 43.23 | Upgrade |
Unlevered Free Cash Flow | -28.9 | -23.45 | -3.5 | 32.58 | 34.93 | 43.23 | Upgrade |
Change in Net Working Capital | 23.55 | 13.27 | 12.98 | -12.37 | 4.01 | -11.96 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.